Search Results - "Hamilton, Jasmine L"
-
1
In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator
Published in Biomaterials (01-09-2016)“…Abstract Desferrioxamine (DFO) is currently in clinical use to remove iron from transfusion-dependent patients with β-thalassemia major, sickle-cell anemia and…”
Get full text
Journal Article -
2
Design of Long Circulating Nontoxic Dendritic Polymers for the Removal of Iron in Vivo
Published in ACS nano (23-12-2013)“…Patients requiring chronic red blood cell (RBC) transfusions for inherited or acquired anemias are at risk of developing transfusional iron overload, which may…”
Get full text
Journal Article -
3
Branched Multifunctional Polyether Polyketals: Variation of Ketal Group Structure Enables Unprecedented Control over Polymer Degradation in Solution and within Cells
Published in Journal of the American Chemical Society (12-09-2012)“…Multifunctional biocompatible and biodegradable nanomaterials incorporating specific degradable linkages that respond to various stimuli and with defined…”
Get full text
Journal Article -
4
Clinically approved iron chelators influence zebrafish mortality, hatching morphology and cardiac function
Published in PloS one (16-10-2014)“…Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox…”
Get full text
Journal Article -
5
Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular Size and Chelator Density
Published in Macromolecular bioscience (01-03-2017)“…Desferrioxamine (DFO) is a clinically approved, high affinity iron chelator used for the treatment of iron overload. Due to its short half‐life and toxicity,…”
Get full text
Journal Article -
6
Polymeric nanocarriers for the treatment of systemic iron overload
Published in Molecular and cellular therapies (24-03-2015)“…Desferrioxamine (DFO), deferiprone (L1) and desferasirox (ICL-670) are clinically approved iron chelators used to treat secondary iron overload. Although iron…”
Get full text
Journal Article -
7
Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function: e109880
Published in PloS one (01-10-2014)“…Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox…”
Get full text
Journal Article